Marketing-authorisation holder · Singapore
Otsuka Pharmaceuticals (Singapore) Pte. Ltd.
20 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · Singapore
20 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
20 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABILIFY ASIMTUFII PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 960MG/3.2ML960mg /3.2ml · Injection, suspension, extended release | Aripiprazole | Singapore | Authorised | 2025 |
| ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION 400 MG400mg/vial · Injection, powder, for suspension, extended release | Aripiprazole | Singapore | Authorised | 2017 |
| ABILIFY MAINTENA POWDER AND SOLVENT FOR PROLONGED RELEASE SUSPENSION FOR INJECTION IN PFS 400mg400mg/syringe · Injection, powder, for suspension, extended release | Aripiprazole | Singapore | Authorised | 2023 |
| ABILIFY ORAL SOLUTION 1MG/ML1.0 mg/ml · Solution | Aripiprazole | Singapore | Authorised | 2021 |
| ABILIFY TABLET 10 mg10.0 mg · Tablet | Aripiprazole | Singapore | Authorised | 2004 |
| ABILIFY TABLET 15 mg15 mg · Tablet | Aripiprazole | Singapore | Authorised | 2004 |
| ABILIFY TABLET 2MG2mg · Tablet | Aripiprazole | Singapore | Authorised | 2021 |
| ABILIFY TABLET 5 mg5.0 mg · Tablet | Aripiprazole | Singapore | Authorised | 2004 |
| JINARC TABLET 15MG15mg · Tablet | Tolvaptan | Singapore | Authorised | 2022 |
| JINARC TABLET 30MG30.000mg · Tablet | Tolvaptan | Singapore | Authorised | 2022 |
| JINARC TABLET 45MG/15MG15.000mg + 45.0mg · Tablet | Tolvaptan | Singapore | Authorised | 2022 |
| JINARC TABLET 60MG/30MG30.000mg + 60.000mg · Tablet | Tolvaptan | Singapore | Authorised | 2022 |
| JINARC TABLET 90MG/30MG30.000mg + 90.0mg · Tablet | Tolvaptan | Singapore | Authorised | 2022 |
| REXULTI FILM-COATED TABLETS 0.25MG0.25mg · Tablet, film coated | Brexpiprazole | Singapore | Authorised | 2019 |
| REXULTI FILM-COATED TABLETS 0.5MG0.5mg · Tablet, film coated | Brexpiprazole | Singapore | Authorised | 2019 |
| REXULTI FILM-COATED TABLETS 1MG1mg · Tablet, film coated | Brexpiprazole | Singapore | Authorised | 2019 |
| REXULTI FILM-COATED TABLETS 2MG2mg · Tablet, film coated | Brexpiprazole | Singapore | Authorised | 2019 |
| REXULTI FILM-COATED TABLETS 3MG3mg · Tablet, film coated | Brexpiprazole | Singapore | Authorised | 2019 |
| REXULTI FILM-COATED TABLETS 4MG4mg · Tablet, film coated | Brexpiprazole | Singapore | Authorised | 2019 |
| SAMSCA TABLET 15MG15mg · Tablet | Tolvaptan | Singapore | Authorised | 2020 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 20 | 20 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.